Ozempic Maker Novo Nordisk Has a Weight Problem
Oct. 23, 2023 11:39 am ETThe company behind diabetes and obesity phenomena Ozempic and Wegovy is overweight.Novo Nordisk became Europe’s ...
Oct. 23, 2023 11:39 am ETThe company behind diabetes and obesity phenomena Ozempic and Wegovy is overweight.Novo Nordisk became Europe’s ...
FTX founder Sam Bankman-Fried, known for his appetite for risky bets, is mulling perhaps his biggest gamble yet: testifying in ...
You would think a new class of high-price weight loss drugs taken by millions of Americans would be a problem ...
Here are some of the major companies whose stocks moved on the week’s news.
Tenet could face labor action next, after Kaiser Permanente workers staged the largest U.S. healthcare walkout on record.
Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ...
What to Read Next
Pentwater Capital predicted that FTC efforts to block big deals would fail.
Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.
VinFast, the Vietnamese electric-vehicle maker, and Arm, a British chip designer, are caught in a weird limbo thanks to their ...